Article Text

Download PDFPDF
Peristomal cutaneous amebiasis causing rapidly progressive necrotic wound of a left lower quadrant end colostomy
  1. Debra Lai1,2,
  2. Byung Kyu Kim3 and
  3. Amir Bastawrous2
  1. 1Lincoln Memorial University, Harrogate, Tennessee, USA
  2. 2Swedish Cancer Institute, Seattle, Washington, USA
  3. 3Pathology Cellnetix, Swedish Medical Center, Seattle, Washington, USA
  1. Correspondence to Dr Debra Lai; debra.lai9{at}gmail.com

Abstract

Cutaneous amebiasis is a rare clinical entity caused by the invasive protozoan parasite Entamoeba histolytica that can be readily diagnosed with skin biopsy if suspected. It presents as a rapidly progressive and destructive ulceration with necrosis. A man in his 40s with metastatic rectal cancer who underwent palliative abdominal perineal resection with end colostomy in his left lower quadrant and on systemic chemotherapy developed progressive breakdown of his peristomal skin unresponsive to antibiotics that was then diagnosed to be cutaneous amebiasis. It is important to be aware of cutaneous amebiasis and include it in the differential diagnosis when peristomal wounds do not respond to treatment.

  • Infection (gastroenterology)
  • Infectious diseases
  • Gastrointestinal surgery
  • General surgery

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Twitter @Debra_Lai

  • Contributors DL wrote the manuscript with review and editing from AB. BKK provided the pathology slide images.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.